Trade APRE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Aprea Therapeutics, Inc. (APRE) is trading at US$0.84, up 5.12% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$8.06M. Over the past 52 weeks, APRE has traded between US$0.55 and US$1.69. On Syfe you can trade APRE with $0 commission and add it to your watchlist.
| Previous close | US$0.79 |
|---|---|
| Market cap | US$8.06M |
| 52-week range | US$0.55 – US$1.69 |
| Volume | 317.74K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.
Year: 2019
--Wedbush Adjusts Price Target on Aprea Therapeutics to $6 From $7, Maintains Outperform Rating
May 14, 10:18 AM · MT Newswires
--Oppenheimer Initiates Aprea Therapeutics at Outperform With $5 Price Target
May 7, 11:58 AM · MT Newswires
Aprea Therapeutics, Inc. (APRE) stock is trading at US$0.84, +5.12% from the previous close of US$0.79.
The market cap for Aprea Therapeutics, Inc. (APRE) stock is approximately US$8.06M.
The 52-week high for Aprea Therapeutics, Inc. (APRE) stock is US$1.69.
The 52-week low for Aprea Therapeutics, Inc. (APRE) stock is US$0.55.
Aprea Therapeutics, Inc. (APRE) does not currently pay a dividend.
Stay on top of APRE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
